In vitro efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites

Babesia and Plasmodium pathogens, the causative agents of babesiosis and malaria, are vector-borne intraerythrocytic protozoan parasites, posing significant threats to both human and animal health. The widespread resistance exhibited by these pathogens to various classes of antiparasitic drugs under...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2024-09, Vol.68 (9), p.e0042324
Main Authors: Vydyam, Pratap, Chand, Meenal, Gihaz, Shalev, Renard, Isaline, Heffernan, Gavin D., Jacobus, Laura R., Jacobus, David P., Saionz, Kurt W., Shah, Raju, Shieh, Hong-Ming, Terpinski, Jacek, Zhao, Wenyi, Cornillot, Emmanuel, Ben Mamoun, Choukri
Format: Article
Language:English
Subjects:
Antimicrobial Chemotherapy
Biosynthesis
Chemistry
Chemistry
Biosynthesis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Babesia and Plasmodium pathogens, the causative agents of babesiosis and malaria, are vector-borne intraerythrocytic protozoan parasites, posing significant threats to both human and animal health. The widespread resistance exhibited by these pathogens to various classes of antiparasitic drugs underscores the need for the development of novel and more effective therapeutic strategies. Antifolates have long been recognized as attractive antiparasitic drugs as they target the folate pathway, which is essential for the biosynthesis of purines and pyrimidines, and thus is vital for the survival and proliferation of protozoan parasites. More efficacious and safer analogs within this class are needed to overcome challenges due to resistance to commonly used antifolates, such as pyrimethamine, and to address liabilities associated with the dihydrotriazines, WR99210 and JPC-2067. Here, we utilized an in vitro culture condition suitable for the continuous propagation of Babesia duncani, Babesia divergens, Babesia MO1, and Plasmodium falciparum in human erythrocytes to screen a library of 50 dihydrotriazines and 29 biguanides for their efficacy in vitro and compared their potency and therapeutic indices across different species and isolates. We identified nine analogs that inhibit the growth of all species, including the P. falciparum pyrimethamine-resistant strain HB3, with IC50 values below 10 nM, and display excellent in vitro therapeutic indices. These compounds hold substantial promise as lead antifolates for further development as broad-spectrum antiparasitic drugs.
ISSN:0066-4804
1098-6596
1098-6596
DOI:10.1128/aac.00423-24